Executive function in methamphetamine users with and without psychosis
•Methamphetamine-induced psychosis is associated with particular executive function subdomain impairments.•Psychosis symptom severity was not associated with scores on the EF composite domains. Methamphetamine abuse is associated with cognitive deficits across a wide range of domains. It is unclear,...
Gespeichert in:
Veröffentlicht in: | Psychiatry research 2022-11, Vol.317, p.114820, Article 114820 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | •Methamphetamine-induced psychosis is associated with particular executive function subdomain impairments.•Psychosis symptom severity was not associated with scores on the EF composite domains.
Methamphetamine abuse is associated with cognitive deficits across a wide range of domains. It is unclear, however, whether methamphetamine-dependent individuals with co-occurring psychosis are more impaired than those without psychosis on tests assessing executive function. We therefore aimed to compare the executive function performance of three groups: methamphetamine-dependent individuals with methamphetamine-induced psychosis (MA+; n = 20), methamphetamine-dependent individuals without psychosis (MA-; n = 19), and healthy controls (HC; n = 20). All participants were administered a neuropsychological test battery that assessed executive functioning across six sub domains (problem solving, working memory, verbal generativity, inhibition, set switching, and decision making). Analyses of covariance (controlling for between-group differences in IQ) detected significant between-group differences on tests assessing verbal generativity and inhibition, with MA+ participants performing significantly more poorly than HC. The finding that methamphetamine-induced psychosis is associated with performance impairments in particular subdomains of executive function may have implications for treatment adherence and relapse prevention. |
---|---|
ISSN: | 0165-1781 1872-7123 |
DOI: | 10.1016/j.psychres.2022.114820 |